Robert Ross Carter - 19 Mar 2025 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role
Chief Financial Officer
Signature
/s/ Mark Hueppelsheuser, Attorney-in-fact for Robert Carter
Issuer symbol
TOI
Transactions as of
19 Mar 2025
Net transactions value
-$1,022
Form type
4
Filing time
20 Mar 2025, 17:56:42 UTC
Previous filing
07 Jan 2025
Next filing
28 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOI Class A Common Stock Disposed to Issuer $1,022 -1,150 -3.7% $0.8890 30,351 19 Mar 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.